{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T13:48:31Z","timestamp":1776779311185,"version":"3.51.2"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"am","delay-in-days":316,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011349","name":"University of Texas at El Paso","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIH National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["5R16GM149379-02"],"award-info":[{"award-number":["5R16GM149379-02"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.cbi.2025.111509","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T02:47:01Z","timestamp":1744339621000},"page":"111509","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Synthesis of novel pyridazine and pyrimidine linked pyrazole derivatives as DNA ligase 1 and IV inhibitors that induce apoptosis"],"prefix":"10.1016","volume":"414","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-4237-5798","authenticated-orcid":false,"given":"S.","family":"Aishwarya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3054-3151","authenticated-orcid":false,"given":"Gabriela C.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9317-5159","authenticated-orcid":false,"given":"Jose A.","family":"Lopez-Saenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denisse A.","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujeet","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashok","family":"Madarakhandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basavaraj","family":"Metikurki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nishith","family":"Teraiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renato J.","family":"Aguilera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5599-3594","authenticated-orcid":false,"given":"Subhas S.","family":"Karki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2025.111509_bib1","unstructured":"https:\/\/www.iarc.who.int\/news-events\/new-report-on-global-cancer-burden-in-2022-by-world-region-and-human-development-level (Accessed on 29 June 2024)."},{"key":"10.1016\/j.cbi.2025.111509_bib2","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3390\/cancers6031769","article-title":"Drug resistance in cancer: an overview","volume":"6","author":"Housman","year":"2014","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cbi.2025.111509_bib3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3390\/ph16020299","article-title":"Nitrogen containing heterocycles as anticancer agents: a medicinal chemistry perspective","volume":"16","author":"Kumar","year":"2014","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.cbi.2025.111509_bib4","doi-asserted-by":"crossref","first-page":"44247","DOI":"10.1039\/D0RA09198G","article-title":"Prescribed drugs containing nitrogen heterocycles: an overview","volume":"10","author":"Majid","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.cbi.2025.111509_bib5","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1080\/00397911.2019.1620282","article-title":"Phenylindole derivatives as anticancer agents: synthesis and screening against murine melanoma, human lung and breast cancer cell lines","volume":"49","author":"Gaikwad","year":"2019","journal-title":"Synth. Commun."},{"key":"10.1016\/j.cbi.2025.111509_bib6","article-title":"Anticancer potetial and structure activity studies of purine and pyrimidine derivatives: an updated review","author":"Manna","year":"2024","journal-title":"Mol. Divers."},{"key":"10.1016\/j.cbi.2025.111509_bib7","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1039\/C7MD00067G","article-title":"Aboul-EneinHY. Imidazoles as potential anticancer agents","volume":"8","author":"AliI","year":"2017","journal-title":"Med. Chem. Comm."},{"key":"10.1016\/j.cbi.2025.111509_bib8","article-title":"A review: FDA-approved fluorine-containing small molecules from 2015 to 2022","volume":"260","author":"Sheikh","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2025.111509_bib9","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1021\/acsomega.3c07624","article-title":"Antiproliferative and apoptotic effects of tempol, methotrexate, and their combinations on the MCF7 breast cancer cell line","volume":"9","author":"Kaplan","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.cbi.2025.111509_bib10","doi-asserted-by":"crossref","first-page":"6881","DOI":"10.1007\/s11164-016-2502-2","article-title":"Design and synthesis of some new tri-substituted pyrazole derivatives as anticancer agents","volume":"42","author":"Fahmy","year":"2016","journal-title":"Res. Chem. Intermed."},{"key":"10.1016\/j.cbi.2025.111509_bib11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13578-018-0200-z","article-title":"Ligase IV inhibitor SCR7 enhances gene editing directed by CRISPR-Cas9 and ssODN in human cancer cells","volume":"8","author":"Hu","year":"2018","journal-title":"Cell Biosci."},{"key":"10.1016\/j.cbi.2025.111509_bib12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bcp.2017.02.015","article-title":"Novel BCL2 inhibitor, Disarib induces apoptosis by disruption of BCL2-BAK interaction","volume":"131","author":"Vartak","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2025.111509_bib13","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3390\/cancers12020466","article-title":"Venetoclax, a BCL-2 inhibitor, enhances the efficacy of chemotherapeutic agents in wild-type ABCG2-overexpression-mediated MDR cancer cells","volume":"12","author":"Wang","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cbi.2025.111509_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202300843","article-title":"Synthesis of novel pyrazole-oxindole conjugates with cytotoxicity in human cancer cells via apoptosis","author":"Jain","year":"2023","journal-title":"Chem. Biodiversity"},{"key":"10.1016\/j.cbi.2025.111509_bib15","doi-asserted-by":"crossref","first-page":"139943","DOI":"10.1016\/j.molstruc.2024.139943","article-title":"Synthesis, molecular docking, dynamics study and preliminary cytotoxicity study of some coumarin linked imidazothiadiazoles","volume":"1321","author":"Sujeet","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.cbi.2025.111509_bib16","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1021\/cr040498d","article-title":"DNA ligases: structure, reaction mechanism, and function","volume":"106","author":"Tomkinson","year":"2006","journal-title":"Chem. Rev."},{"key":"10.1016\/j.cbi.2025.111509_bib17","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1146\/annurev.biochem.77.061306.123941","article-title":"Eukaryotic DNA ligases: structural and functional insights","volume":"77","author":"Ellenberger","year":"2008","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.cbi.2025.111509_bib18","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/med.21298","article-title":"Human DNA ligases: a comprehensive new look for cancer therapy","volume":"34","author":"Singh","year":"2014","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.cbi.2025.111509_bib19","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/nrmicro1768","article-title":"Bacterial DNA repair by non-homologous end joining","volume":"5","author":"Shuman","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.cbi.2025.111509_bib20","first-page":"1219","article-title":"DNA ligases as therapeutic targets, Transl","volume":"2","author":"Tomkinson","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.cbi.2025.111509_bib21","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/mc.22516","article-title":"Identification and characterization of novel ligase I inhibitors","volume":"56","author":"Pandey","year":"2017","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.cbi.2025.111509_bib22","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/j.cell.2012.11.054","article-title":"An inhibitor of nonhomologous end-joining abrogates double-strand break repair and impedes cancer progression","volume":"151","author":"Srivastava","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.cbi.2025.111509_bib23","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/mabi.201400480","article-title":"Enhanced efficacy of pluronic copolymer micelle encapsulated SCR7 against cancer cell proliferation","volume":"15","author":"John","year":"2015","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.cbi.2025.111509_bib24","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1111\/febs.14661","article-title":"Autocyclized and oxidized forms of SCR7 induce cancer cell death by inhibiting nonhomologous DNA end joiningin a Ligase IV dependent manner","volume":"21","author":"Vartak","year":"2018","journal-title":"FEBS J."},{"key":"10.1016\/j.cbi.2025.111509_bib25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/jrcr.jrcr_24_18","volume":"10","author":"Pandey","year":"2019","journal-title":"Radiat. Cancer Res."},{"key":"10.1016\/j.cbi.2025.111509_bib26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3390\/11010043","article-title":"Synthesis of some new 2-(3-aryl-1-phenyl-4-pyrazolyl)-benzoxazoles using hypervalent iodine mediated oxidative cyclization of Schiff's bases","volume":"11","author":"Prakash","year":"2006","journal-title":"Molecules"},{"key":"10.1016\/j.cbi.2025.111509_bib27","first-page":"1","article-title":"Differential nuclear stainingassayforhigh-throughputscreeningtoidentifycytotoxiccompounds","volume":"1","author":"Lema","year":"2011","journal-title":"Curr. Cell Biochem."},{"key":"10.1016\/j.cbi.2025.111509_bib28","article-title":"Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","author":"Trott","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.cbi.2025.111509_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107323","article-title":"PI3K\u03b4 and mTOR dual inhibitors: design, synthesis and anticancer evaluation of 3-substituted aminomethylquinoline analogues","volume":"147","author":"Yevale","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.cbi.2025.111509_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116917","article-title":"Discovery of new pyrazole-4-carboxamide analogues as potential anticancer agents targeting dual aurora kinase A and B","volume":"280","author":"Yevale","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2025.111509_bib31","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/sj.cdd.4400476","article-title":"Emerging roles of caspase-3 in apoptosis","volume":"6","author":"Porter","year":"1999","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cbi.2025.111509_bib32","doi-asserted-by":"crossref","first-page":"17545","DOI":"10.1073\/pnas.0507900102","article-title":"Formation of apoptosome is initiated by cytochrome c-induced dATP hydrolysis and subsequent nucleotide exchange on Apaf-1","volume":"102","author":"Kim","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279725001395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279725001395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T19:51:18Z","timestamp":1762113078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279725001395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":32,"alternative-id":["S0009279725001395"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2025.111509","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis of novel pyridazine and pyrimidine linked pyrazole derivatives as DNA ligase 1 and IV inhibitors that induce apoptosis","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2025.111509","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111509"}}